Review Article

The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis

Table 1

Characteristics of included studies.

StudyMedical conditionCountry FDC armSeparate pills armDuration of follow-upAdherence assessment method

Eron et al., 2000 [15]223HIV infectionUSAFCD of lamivudine and zidovudine in combination with a PISeparate lamivudine, zidovudine, and a PI4 monthsSelf-reported adherence

Sosa et al., 2005 [16]236HIV infectionUSA, Panama, Costa Rica, Puerto RicoOnce daily FDC of abacavir and lamivudine in combination with a PI or NNRTITwice daily separate abacavir and lamivudine in combination with a PI or NNRTI12 monthsPill count

Geiter et al., 1987 [17]538Pulmonary tuberculosisUSAFDC of isoniazid, rifampicin, and pyrazinamide for 2 months followed by FDC of isoniazid and rifampin for 4 monthsSeparate isoniazid, rifampicin, and pyrazinamide for 2 months followed by separate isoniazid and rifampin for 4 months6 monthsSelf-reported adherence, pill count, and appointment keeping

Su and Perng, 2002 [18]105Pulmonary tuberculosisTaiwanFDC of isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months, followed by FDC of isoniazid and rifampicin for 4 monthsSeparate isoniazid, rifampicin, pyrazinamide, and ethambutol for 2 months, followed by separate isoniazid and rifampicin for 4 months12 monthsAdherence with clinic visits

RCTAI, 1989 [19]196Pulmonary tuberculosisIndiaFDC of isoniazid, rifampicin, and pyrazinamide for 8 weeks followed by FDC of isoniazid and rifampin for 18 weeksSeparate isoniazid, rifampicin, and pyrazinamide for 8 weeks followed by separate of isoniazid and rifampin for 18 weeks26 weeksHome based pill counts

Asplund et al., 1984 [20]160HypertensionSwedenFDC of pindolol and clopamideSeparate pindolol and clopamide8 monthsPill count